Literature DB >> 23101426

Clostridium difficile infection and partial membrane cofactor protein (CD46) deficiency.

Eran Kalmanovich1, Ofra Kriger-Sharabi, Eli Shiloah, Natali Donin, Zvi Fishelson, Micha J Rapoport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23101426

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  3 in total

1.  Clostridioides difficile-Associated Atypical Hemolytic-Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.

Authors:  Michael N Moulton; Carl L Kay; Joshua T Romain; Benjamin D Morrow; Gilda M Bobele
Journal:  Crit Care Explor       Date:  2021-07-13

2.  Atypical Haemolytic Uraemic Syndrome Associated with Clostridium difficile Infection Successfully Treated with Eculizumab.

Authors:  Joshua M Inglis; Jeffrey A Barbara; Rajiv Juneja; Caroline Milton; George Passaris; Jordan Y Z Li
Journal:  Case Rep Nephrol       Date:  2018-05-10

3.  A case report of a child with sepsis induced multiorgan failure and massive complement consumption treated with a short course of Eculizumab: A case of crosstalk between coagulation and complement?

Authors:  Slobodan Galic; Dorottya Csuka; Zoltán Prohászka; Daniel Turudic; Petra Dzepina; Danko Milosevic
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.